GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Rennova Health Inc (OTCPK:RNVA) » Definitions » Cash-to-Debt

RNVA (Rennova Health) Cash-to-Debt : 0.00 (As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Rennova Health Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Rennova Health's cash to debt ratio for the quarter that ended in Dec. 2023 was 0.00.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Rennova Health couldn't pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Rennova Health's Cash-to-Debt or its related term are showing as below:

RNVA's Cash-to-Debt is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 0.92
* Ranked among companies with meaningful Cash-to-Debt only.

Rennova Health Cash-to-Debt Historical Data

The historical data trend for Rennova Health's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Rennova Health Cash-to-Debt Chart

Rennova Health Annual Data
Trend Mar14 Mar15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash-to-Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.05 0.03 -

Rennova Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.02 0.06 0.01 -

Competitive Comparison of Rennova Health's Cash-to-Debt

For the Diagnostics & Research subindustry, Rennova Health's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rennova Health's Cash-to-Debt Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Rennova Health's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Rennova Health's Cash-to-Debt falls into.


;
;

Rennova Health Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Rennova Health's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Rennova Health's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rennova Health  (OTCPK:RNVA) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Rennova Health Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Rennova Health's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Rennova Health Business Description

Traded in Other Exchanges
N/A
Address
477 S. Rosemary Avenue, Suite 800, West Palm Beach, FL, USA, 33401
Rennova Health Inc is a vertically integrated provider of healthcare-related products and services. The company operates through a single business segment namely the Hospital operations segment reflects the purchase of the hospital assets. Geographically, the activities are carried out throughout the region of the US.
Executives
Jonathan Immordino officer: Chief Financial Officer 3340, POSEIDON WAY, INDIALANTIC FL 32903
Marlene Mclennan officer: Chief Financial Officer 400 SOUTH AUSTRALIAN AVENUE, SUITE 800, WEST PALM BEACH FL 33401
Gary L Blum director 3278 WILSHIRE BOULEVARD, SUITE 603, LOS ANGELES, CALIFORNIA CA 90010
John Beach director 400 S. AUSTRALIAN AVENUE,, SUITE 800,, WEST PALM BEACH, FL 33401
Kamran Ajami director 3920 NW 43RD ST., COCONUT CREEK FL 33073
Trevor Langley director 1000 N. GREEN VALLEY PARKWAY, #440-420, HENDERSON NV 89074
Michael H Pollack officer: Interim CFO 114 WEST 47TH STREET, 19TH FLOOR, NEW YORK NY 10036
Sharon Lynne Hollis 10 percent owner 400 SOUTH AUSTRALIAN AVENUE, 8TH FLOOR, WEST PALM BEACH FL 33401
Robert P Lee director 400 S. AUSTRALIAN AVE., #800, WEST PALM BEACH FL 33134
Aella, Ltd. 10 percent owner SUITE 104A, SAFFREY SQUARE, BANK LANE, PO BOX N-9306, NASSAU C5 000000
Epizon Ltd. 10 percent owner SUITE 104A, SAFFREY SQUARE, BANK LANE, PO BOX N-9306, NASSAU C5 000000
Michael Louis Goldberg director 2008 BAYVIEW DRIVE, FORT LAUDERDALE FL 33305
Benjamin Frank director 400 SOUTH AUSTRALIAN AVENUE, 8TH FLOOR, WEST PALM BEACH FL 33401
Jason Adams officer: Chief Financial Officer 4700 SANTA DEL RAE AVENUE, FT MYERS FL 33901
George Lundberg officer: Editor in Chief and CMO 44 MONTGOMERY STREET, SUITE 800, SAN FRANCISCO CA 94104